Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q


(Mark One)

     
x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
     
    For the quarterly period ended March 30, 2003 or
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 000-12933


 
 
LAM RESEARCH CORPORATION

(Exact name of registrant as specified in its charter)
     
Delaware   94-2634797

 
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification Number)
 
4650 Cushing Parkway
Fremont, California 94538

(Address of principal executive offices including zip code)
 
(510) 572-0200
(Registrant’s telephone number, including area code)

 


     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days.   YES x   NO o

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).   YES x   NO o

     As of May 2, 2003, there were 126,819,270 shares of Registrant’s Common Stock outstanding.
 
 


 


TABLE OF CONTENTS

PART I. Financial Information
Item 1. Financial Statements (unaudited):
Condensed Consolidated Balance Sheets as of March 30, 2003 and June 30, 2002
Condensed Consolidated Statements of Operations for the three and nine months ended March 30, 2003 and March 31, 2002
Condensed Consolidated Statements of Cash Flows for the nine months ended March 30, 2003 and March 31, 2002
Notes to Condensed Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Item 4. Controls and Procedures
PART II. Other Information
Item 1. Legal Proceedings
Item 6. Exhibits and Reports on Form 8-K
Signatures
Certifications
EXHIBIT 10.80
EXHIBIT 10.81
EXHIBIT 10.82
EXHIBIT 10.83
EXHIBIT 10.84
EXHIBIT 10.85
EXHIBIT 99.1
EXHIBIT 99.2


Table of Contents

LAM RESEARCH CORPORATION
TABLE OF CONTENTS

           
      Page No.  
     
 
PART I. Financial Information
       
 
       
Item 1. Financial Statements (unaudited):
    3  
 
       
 
Condensed Consolidated Balance Sheets as of March 30, 2003 and June 30, 2002
    3  
 
       
 
Condensed Consolidated Statements of Operations for the three and nine months ended March 30, 2003 and March 31, 2002
    4  
 
       
 
Condensed Consolidated Statements of Cash Flows for the nine months ended March 30, 2003 and March 31, 2002
    5  
 
       
 
Notes to Condensed Consolidated Financial Statements
    6  
 
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
    24  
 
       
Item 3. Quantitative and Qualitative Disclosures about Market Risk
    51  
 
       
Item 4. Controls and Procedures
    51  
 
       
PART II. Other Information
    51  
 
       
Item 1. Legal Proceedings
    51  
 
       
 
       
Item 6. Exhibits and Reports on Form 8-K
    52  
 
       
Signatures
    53  
 
       
Certifications
    54  

2


Table of Contents

PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

                   
      March 30,     June 30,  
      2003     2002  
      (unaudited)     (1)  
     
   
 
Assets
               
Cash and cash equivalents
  $ 96,406     $ 172,431  
Short-term investments
    369,460       701,774  
Accounts receivable, net
    133,110       132,113  
Inventories
    126,690       180,799  
Deferred income taxes
    128,577       125,227  
Other current assets
    17,750       43,080  
 
 
   
 
 
Total current assets
    871,993       1,355,424  
Property and equipment, net
    53,242       67,496  
Restricted cash
    119,438       70,983  
Deferred income taxes
    88,307       86,231  
Other assets
    62,880       52,157  
 
 
   
 
 
Total assets
  $ 1,195,860     $ 1,632,291  
 
 
   
 
Liabilities and stockholders’ equity
               
Trade accounts payable
  $ 30,622     $ 59,806  
Accrued expenses and other current liabilities
    161,430       159,012  
Deferred profit
    47,315       63,435  
Current portion of long-term debt and other long-term liabilities
    5,160       315,291  
 
 
   
 
 
Total current liabilities
    244,527       597,544  
Long-term debt and other long-term liabilities less current portion
    321,718       359,691  
 
 
   
 
 
Total liabilities
    566,245       957,235  
Commitments and contingencies
               
Preferred stock, at par value of $0.001 per share; authorized — 5,000 shares, none outstanding
           
Common stock, at par value of $0.001 per share; authorized — 400,000 shares; issued and outstanding — 126,150 shares at March 30, 2003 and 127,978 shares at June 30, 2002
    126       128  
Additional paid-in capital
    551,752       542,228  
Deferred compensation
    (2,979 )      
Treasury stock, at cost
    (44,508 )     (9,100 )
Accumulated other comprehensive loss
    (16,681 )     (15,240 )
Retained earnings
    141,905       157,040  
 
 
   
 
 
Total stockholders’ equity
    629,615       675,056  
 
 
   
 
 
Total liabilities and stockholders’ equity
  $ 1,195,860     $ 1,632,291  
 
 
   
 

(1) Derived from June 30, 2002 audited financial statements.

See Notes to Condensed Consolidated Financial Statements.

3


Table of Contents

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)
(unaudited)

                                   
      Three Months Ended     Nine Months Ended  
     
   
 
      March 30,     March 31,     March 30,     March 31,  
      2003     2002     2003     2002  
     
   
   
   
 
Total revenue
  $ 187,059     $ 164,105     $ 569,148     $ 762,858  
 
Cost of goods sold
    111,838       109,118       342,744       516,732  
 
Cost of goods sold — restructuring charges (recoveries)
                (301 )     7,600  
 
Cost of goods sold — patent settlement
                      38,780  
 
 
   
   
   
 
Total cost of goods sold
    111,838       109,118       342,443       563,112  
 
 
   
   
   
 
Gross margin
    75,221       54,987       226,705       199,746  
 
 
   
   
   
 
 
Research and development
    38,981       40,552       120,102       137,516  
 
Selling, general and administrative
    33,245       36,849       98,319       127,538  
 
Restructuring charges, net
    4,043             6,096       47,221  
 
 
   
   
   
 
Total operating expenses
    76,269       77,401       224,517       312,275  
 
 
   
   
   
 
Operating income (loss)
    (1,048 )     (22,414 )     2,188       (112,529 )
Other income (expense), net
    2,110       17,443       (11,970 )     17,762  
 
 
   
   
   
 
Income (loss) before income taxes
    1,062       (4,971 )     (9,782 )     (94,767 )
Income tax expense (benefit)
    265       (6,540 )     1,656       (35,761 )
 
 
   
   
   
 
Net income (loss)
  $ 797     $ 1,569     $ (11,438 )   $ (59,006 )
 
 
   
   
   
 
Net income (loss) per share:
                               
 
Basic net income (loss) per share
  $ 0.01     $ 0.01     $ (0.09 )   $ (0.47 )
 
 
   
   
   
 
 
Diluted net income (loss) per share
  $ 0.01     $ 0.01     $ (0.09 )   $ (0.47 )
 
 
   
   
   
 
Number of shares used in per share calculations:
                               
 
Basic
    125,988       126,747       126,110       125,921  
 
 
   
   
   
 
 
Diluted
    129,550       134,420       126,110       125,921  
 
 
   
   
   
 

See Notes to Condensed Consolidated Financial Statements.

4


Table of Contents

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

(unaudited)

                   
      Nine Months Ended  
     
 
      March 30,     March 31,  
      2003     2002  
     
   
 
Cash flows from operating activities:
               
 
Net loss
  $ (11,438 )   $ (59,006 )
 
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
               
 
Loss (gain) on equity derivative contracts in company stock
    16,407       (17,718 )
 
Depreciation and amortization
    30,504       46,332  
 
Amortization of premiums on securities
    4,641       5,424  
 
Deferred income taxes
    (5,426 )     (39,736 )
 
Restructuring charges, net
    5,795       54,821  
 
Patent settlement
          33,780  
 
Asset impairment charge
          11,500  
 
Amortization of deferred compensation
    383        
 
Other
    354       1,730  
 
Change in working capital accounts
    (3,676 )     (55,907 )
 
 
   
 
Net cash provided by/(used for) operating activities
    37,544       (18,780 )
 
 
   
 
Cash flows from investing activities:
               
 
Capital expenditures
    (9,528 )     (8,518 )
 
Purchases of available-for-sale securities
    (360,339 )     (2,097,734 )
 
Sales and maturities of available-for-sale securities
    688,012       2,034,838  
 
Purchase of investments for restricted cash, net
    (48,455 )      
 
Other, net
    1,333       (10,035 )
 
 
   
 
Net cash provided by/(used for) investing activities
    271,023       (81,449 )
 
 
   
 
Cash flows from financing activities:
               
 
Principal payments and redemptions on long-term debt and capital lease obligations
    (361,259 )     (6,909 )
 
Treasury stock purchases
    (39,122 )     (10,678 )
 
Reissuances of treasury stock
    8,448       12,324  
 
Proceeds from issuance of common stock
    6,160       14,270  
 
 
   
 
Net cash provided by/(used for) financing activities
    (385,773 )     9,007  
 
 
   
 
 
Effect of exchange rate changes on cash
    1,181       (352 )
 
 
   
 
Net decrease in cash and cash equivalents
    (76,025 )     (91,574 )
Cash and cash equivalents at beginning of period
    172,431       221,659  
 
 
   
 
Cash and cash equivalents at end of period
  $ 96,406     $ 130,085  
 
 
   
 

See Notes to Condensed Consolidated Financial Statements.

5


Table of Contents

LAM RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 30, 2003

(Unaudited)

NOTE A — BASIS OF PRESENTATION

     The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of Lam Research Corporation (the “Company” or “Lam”) for the fiscal year ended June 30, 2002, which are included in the Annual Report on Form 10-K, File Number 0-12933. The Company’s Form 10-K, Forms 10-Q and Forms 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is http://www.sec.gov. The Company also posts the Form 10-K, Forms 10-Q and Forms 8-K on the corporate website at http://www.lamrc.com.

     The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 29, 2003 and includes 52 weeks. The quarters ended March 30, 2003 and March 31, 2002 included 13 weeks.

     Reclassifications: Certain amounts presented in the comparative financial statements for prior years have been reclassified to conform to the 2003 presentation.

NOTE B — RECENT ACCOUNTING PRONOUNCEMENTS

     Impairment or Disposals of Long-Lived Assets: In August 2001, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards No. 144 (“FAS 144”) “Accounting for the Impairment or Disposal of Long-Lived Assets”. FAS 144 supersedes FAS No. 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of”, and applies to all long-lived assets (including discontinued operations). The Company adopted FAS 144 effective at the beginning of fiscal 2003. The adoption of FAS 144 did not have a material impact on the Company’s consolidated financial position or operating results.

     Costs associated with Exit or Disposal Activities: In July 2002, the FASB issued Statement of Financial Accounting Standards No. 146 “Accounting for Costs Associated with Exit or Disposal Activities” (“FAS 146”). FAS 146 addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies Emerging Issues Task Force Issue No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring)” (“EITF 94-3”). The principal difference between FAS 146 and EITF 94-3 relates to FAS 146’s requirements for the timing of recognizing a liability for a cost associated with an exit or disposal activity. FAS 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when

6


Table of Contents

the liability is incurred. Under EITF 94-3 a liability for an exit cost was recognized at the date of an entity’s commitment to an exit plan. FAS 146 is effective for exit or disposal activities that are initiated after December 31, 2002, with early adoption encouraged. The Company early-adopted FAS 146 in the quarter ended December 29, 2002 and applied its accounting provisions to the restructuring activities initiated during the quarters ended December 29, 2002 and March 30, 2003 (see Note N). No restructuring activities were initiated during the quarter ended September 29, 2002.

     Accounting for Revenue Arrangements with Multiple Deliverables: In November 2002, the FASB’s Emerging Issues Task Force reached a consensus on EITF Issue No. 00-21, “Accounting for Revenue Arrangements with Multiple Deliverables” (“EITF 00-21”). EITF 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple deliverables (products, services and/or rights to use assets). The provisions of EITF 00-21 will be applicable for revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The Company is reviewing EITF 00-21 but has not yet determined the potential impact it will have on the Company’s financial position or results of operations, if any.

     Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others: In November 2002, the FASB issued Interpretation No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others” (“FIN 45”). FIN 45 requires a company that is a guarantor to make specific disclosures about its obligations under certain guarantees that it has issued. FIN 45 also requires the guarantor to recognize, at the inception of a guarantee, a liability for the fair value of the obligations it has undertaken in issuing the guarantee. FIN 45 also incorporates, without change, the guidance in FASB Interpretation No. 34, “Disclosure of Indirect Guarantees of Indebtedness of Others” which is superseded by FIN 45. FIN 45’s disclosure requirements are effective for financial statements for periods ending after December 15, 2002. The initial recognition and initial measurement provisions of FIN 45 are applicable on a prospective basis to guarantees issued after December 31, 2002. The provisions of FIN 45 did not have a material impact on the Company’s financial position or results of operations upon adoption. (See Note L).

     Accounting for Stock-Based Compensation — Transition and Disclosure: In December 2002, the FASB issued Statement of Financial Accounting Standards No. 148, “Accounting for Stock-Based Compensation-Transition and Disclosure” (“FAS 148”), which amends Statement of Financial Accounting Standards No. 123, “Accounting for Stock-Based Compensation”, (“FAS 123”). FAS 148 provides alternative methods of transition for a voluntary change to the “fair value” method of accounting for stock-based employee compensation. In addition, FAS 148 amends the disclosure requirements of FAS 123 and requires prominent disclosure in both annual and interim financial statements of the method of accounting for stock-based employee compensation and the effect of the method used on a company’s financial position and results of operations. The transition guidance and annual disclosure requirements of FAS 148 are effective for fiscal years ending after December 15, 2002. The Company adopted the interim disclosure requirements of FAS 148 for financial statements in its fiscal quarter ended March 30, 2003. The Company intends to continue to account for its stock option plans and stock purchase plan under the provisions of Accounting Principles Board Opinion No. 25 “Accounting For Stock Issued to Employees” (“APB 25”) and Interpretation No. 44, “Accounting for Certain Transactions Involving Stock Compensation — an Interpretation of APB Opinion No. 25” (“FIN 44”).

7


Table of Contents

Accordingly, the adoption of FAS 148 is not anticipated to have a material impact on the Company’s financial position or results of operations.

     Consolidation of Variable Interest Entities: In January 2003, the FASB issued Interpretation No. 46, “Consolidation of Variable Interest Entities” (“FIN 46”), an interpretation of Accounting Research Bulletin No. 51, “Consolidated Financial Statements”. FIN 46 establishes accounting guidance for consolidation of a variable interest entity (“VIE”), sometimes formerly referred to as a special purpose entity. In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources for the entity to support its activities. FIN 46 applies to any business enterprise, both public and private, that has a controlling interest, contractual relationship or other business relationship with a VIE. FIN 46 provides guidance for determining when an entity, the Primary Beneficiary, should consolidate another entity, a VIE, that functions to support the activities of the Primary Beneficiary. FIN 46 will require the consolidation of a VIE by a company if that company is subject to a majority of the risk of loss from the VIE’s activities or entitled to receive a majority of the VIE’s residual returns or both.

     The effective date of the new rules under FIN 46 on the Company’s existing operating leases is the first quarter of fiscal 2004, and immediately on any new leases entered into after January 31, 2003, which utilize VIEs or equivalent lease structures. The adoption of FIN 46 could potentially result in the Company having to consolidate the operating results of certain existing lessor entities which may be VIEs, as defined, and which are lessors under some of the Company’s operating lease agreements and recognize the assets and related liabilities of the VIEs on the Company’s balance sheet. However, FIN 46 is not anticipated to have a material impact on the Company’s financial position or results of operations because the Company anticipates the operating lease agreements will be transferred to a new lessor that would not qualify as a VIE.

NOTE C — STOCK-BASED COMPENSATION PLANS

     The Company has adopted stock option plans that provide for the grant to key employees of options to purchase shares of Lam common stock. In addition, the plans permit the grant of nonstatutory stock options to paid consultants and employees, and provide for the automatic grant of nonstatutory stock options to outside directors. The Company also has a stock purchase plan that allows employees to purchase its common stock. The Company accounts for its stock option plans and stock purchase plan under the provisions of APB 25 and FIN 44.

     For pro forma purposes, the estimated fair value of the Company’s stock-based awards is amortized over the options’ vesting period (for options) and the respective four, six, twelve, or fifteen-month purchase periods (for stock purchases under the employee stock purchase plan). The following table illustrates the effect on net income (loss) and net income (loss) per share if the Company had accounted for its stock option and stock purchase plans under the fair value method of accounting under FAS 123, as amended by FAS 148:

8


Table of Contents

                                 
    Three Months Ended     Nine Months Ended  
   
   
 
    March 30,     March 31,     March 30,     March 31,  
    2003     2002     2003     2002  
   
   
   
   
 
    (in thousands, except per share amounts)  
Net income (loss) — as reported
  $ 797     $ 1,569     $ (11,438 )   $ (59,006 )
Add: compensation expense recorded under APB 25, net of tax
    329             458       1,718  
Deduct: FAS 123 compensation expense, net of tax
    10,297       8,031       33,537       24,579  
 
 
   
   
   
 
Net loss — pro forma
  $ (9,171 )   $ (6,462 )   $ (44,517 )   $ (81,867 )
 
 
   
   
   
 
Basic net income (loss) per share — as reported
  $ 0.01     $ 0.01     $ (0.09 )   $ (0.47 )
 
 
   
   
   
 
Basic loss per share — pro forma
  $ (0.07 )   $ (0.05 )   $ (0.35 )   $ (0.65 )
 
 
   
   
   
 
Diluted net income (loss) per share — as reported
  $ 0.01     $ 0.01     $ (0.09 )   $ (0.47 )
 
 
   
   
   
 
Diluted loss per share — pro forma
  $ (0.07 )   $ (0.05 )   $ (0.35 )   $ (0.65 )